IL203051A - Use of alpha-ketoglutarate for drug preparation - Google Patents
Use of alpha-ketoglutarate for drug preparationInfo
- Publication number
- IL203051A IL203051A IL203051A IL20305109A IL203051A IL 203051 A IL203051 A IL 203051A IL 203051 A IL203051 A IL 203051A IL 20305109 A IL20305109 A IL 20305109A IL 203051 A IL203051 A IL 203051A
- Authority
- IL
- Israel
- Prior art keywords
- ketoglutarate
- medicaments
- alpha
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07460015A EP1917959B1 (en) | 2006-07-03 | 2007-07-03 | New medical use of alfa-ketoglutarate |
PCT/PL2007/000086 WO2009005379A1 (en) | 2007-07-03 | 2007-12-31 | New medical applications of alpha-ketoglutarate |
Publications (1)
Publication Number | Publication Date |
---|---|
IL203051A true IL203051A (en) | 2014-07-31 |
Family
ID=39322797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL203051A IL203051A (en) | 2007-07-03 | 2009-12-30 | Use of alpha-ketoglutarate for drug preparation |
Country Status (5)
Country | Link |
---|---|
JP (2) | JP5518702B2 (ko) |
KR (2) | KR20150003908A (ko) |
CN (2) | CN102014888A (ko) |
IL (1) | IL203051A (ko) |
WO (1) | WO2009005379A1 (ko) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201400567QA (en) | 2011-10-11 | 2014-05-29 | Medimmune Llc | Cd40l-specific tn3-derived scaffolds and methods of use thereof |
CN103168972A (zh) * | 2013-04-19 | 2013-06-26 | 中国水产科学研究院黑龙江水产研究所 | 一种提高鲤鱼生长性能和蛋白质沉积的饲料 |
RU2673473C2 (ru) * | 2013-12-27 | 2018-11-27 | Колгейт-Палмолив Компани | Пребиотические композиции для ухода за полостью рта, содержащие карбоновые кислоты |
CN104257643B (zh) * | 2014-09-15 | 2016-09-21 | 华南理工大学 | 基于α-酮戊二酸的泌尿系磷酸盐结石的溶石剂及其制备方法 |
CN104721176B (zh) * | 2015-02-02 | 2018-07-10 | 中山大学 | α-酮戊二酸在提高细菌对抗生素敏感性方面的应用 |
EP3268389B1 (en) | 2015-03-12 | 2020-09-30 | Medimmune, LLC | Method of purifying albumin-fusion proteins |
CN105325731A (zh) * | 2015-12-07 | 2016-02-17 | 湖南农业大学 | α-酮戊二酸作为饲料添加剂的用途及相应饲料 |
CN105475230B (zh) * | 2015-12-17 | 2018-04-20 | 中国农业大学 | 一种提高大龄动物繁殖力的方法 |
LU100900B1 (de) * | 2018-08-10 | 2020-02-17 | Thomas Melchior Homann | Verbindungen zur modulation von a-ketoglutarsäure (2kg)-abhängigen oxygenasen |
JP2022504792A (ja) * | 2018-10-10 | 2022-01-13 | セルバトゥス リミテッド | 炎症性疾患及び関連する感染の治療方法 |
AU2020292062B2 (en) * | 2019-06-14 | 2024-01-18 | Cj Cheiljedang Corporation | Composition for preventing, treating, or improving gastrointestinal diseases comprising strain of genus Corynebacterium and culture thereof |
WO2021136765A1 (en) * | 2019-12-30 | 2021-07-08 | Devicare, S.L. | Compositions for clinical complications associated to devices implanted in the urinary tract |
CN111067885A (zh) * | 2020-02-20 | 2020-04-28 | 杨益文 | 一种消除幽门螺旋螺杆菌及治疗胃及十二指肠溃疡的药物 |
CN111820330A (zh) * | 2020-07-17 | 2020-10-27 | 禹城保立康生物饲料有限公司 | 一种提高哺乳仔猪发育的母猪饲料 |
CN113337436A (zh) * | 2021-06-09 | 2021-09-03 | 中国科学院新疆生态与地理研究所 | 一种尿素分解菌及其选育方法和应用 |
CN113995054A (zh) * | 2021-11-02 | 2022-02-01 | 中国科学院亚热带农业生态研究所 | 鸟氨酸-α-酮戊二酸在制备促进保育猪生长饲料中的应用 |
CN115340313B (zh) * | 2022-01-17 | 2023-04-18 | 浙江理工大学 | 一种物理复合微生物技术强化再生骨料方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4919855B1 (ko) * | 1970-10-06 | 1974-05-21 | ||
SE9303691D0 (sv) * | 1993-11-09 | 1993-11-09 | Gramineer Ab | New beverage |
JP2002529545A (ja) * | 1998-11-06 | 2002-09-10 | ユニベルシテ ドゥ モントリオール | バイオフィルムを除去するための改良型の殺菌性及び非殺菌性溶液 |
JP4533496B2 (ja) * | 2000-03-15 | 2010-09-01 | 三菱重工業株式会社 | バイオマスからの燃料製造方法 |
EP1184443A1 (en) * | 2000-09-04 | 2002-03-06 | Biofuel B.V. | Process for the production of liquid fuels from biomass |
FR2822704B1 (fr) * | 2001-03-29 | 2005-02-18 | Chiesi Sa | Sels de cetoacides et d'acides amines gastroresistants et leur utilisation pour la preparation de medicaments |
SE0200256D0 (sv) * | 2001-12-21 | 2002-01-29 | Gramineer Internat Ab | New composition, methods and use |
PL368572A1 (en) * | 2004-06-17 | 2005-12-27 | Sgp & Sons Ab | Pharmaceutical compound for prevention and therapy of increased level of cholesterol, ldl and triglycerides as well as application of the pharmaceutical compound as an agent acting against atherosclerosis and used in circulatory system affections |
EP1778616A1 (en) * | 2004-08-09 | 2007-05-02 | Cancer Research Technology Limited | Alpha-ketoglutarates and their use as therapeutic agents |
WO2006043336A1 (ja) * | 2004-10-20 | 2006-04-27 | Kotobuki Pharmaceutical Co., Ltd. | 胃粘膜疾患の治療又は予防のための組成物 |
US7803817B2 (en) * | 2005-05-11 | 2010-09-28 | Vecta, Ltd. | Composition and methods for inhibiting gastric acid secretion |
-
2007
- 2007-12-31 CN CN2007801004718A patent/CN102014888A/zh active Pending
- 2007-12-31 JP JP2010514670A patent/JP5518702B2/ja not_active Expired - Fee Related
- 2007-12-31 KR KR1020147033914A patent/KR20150003908A/ko not_active Application Discontinuation
- 2007-12-31 WO PCT/PL2007/000086 patent/WO2009005379A1/en active Application Filing
- 2007-12-31 CN CN201510209789.6A patent/CN104825433A/zh active Pending
- 2007-12-31 KR KR1020107002525A patent/KR101610791B1/ko not_active IP Right Cessation
-
2009
- 2009-12-30 IL IL203051A patent/IL203051A/en not_active IP Right Cessation
-
2014
- 2014-04-02 JP JP2014076402A patent/JP2014193866A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20150003908A (ko) | 2015-01-09 |
JP5518702B2 (ja) | 2014-06-11 |
CN104825433A (zh) | 2015-08-12 |
KR20100053546A (ko) | 2010-05-20 |
JP2014193866A (ja) | 2014-10-09 |
JP2010532347A (ja) | 2010-10-07 |
KR101610791B1 (ko) | 2016-04-11 |
CN102014888A (zh) | 2011-04-13 |
WO2009005379A1 (en) | 2009-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL203051A (en) | Use of alpha-ketoglutarate for drug preparation | |
IL226702A (en) | Therapeutic isoxazole compounds for drug preparation | |
HK1211889A1 (en) | Therapeutic use of diaminophenothiazines | |
EP2211620A4 (en) | THERAPEUTIC COMPOUNDS | |
HK1141013A1 (en) | Process for the preparation of certain substituted sulfilimines | |
IL210549A (en) | Pipedrine - Quinocosalin-Mediated Conjugated Drugs | |
GB0716532D0 (en) | Therapeutic compounds | |
GB0813087D0 (en) | Therapeutic compounds | |
EP2164324A4 (en) | THERAPEUTIC COMPOUNDS | |
ZA200907191B (en) | Process for the preparation of gefitiib | |
GB0721332D0 (en) | Medicaments | |
HK1161555A1 (en) | Use of an antiprolactinic veterinary composition for the manufacture of a medicament | |
IL199697A0 (en) | Therapeutical uses of eslicarbazepine | |
GB0715790D0 (en) | Drug combination for the treatment of sialorrhoea | |
EP2185568A4 (en) | THERAPEUTIC COMPOUNDS | |
HUP0700756A2 (en) | Process for the preparation of pharmaceutical intermediers | |
EP2157089A4 (en) | THERAPEUTIC USES OF IMIDAZOL-5-CARBOXYLIC ACID DERIVATIVES | |
GB2464854B (en) | Process for the preparation of risperidone | |
GB0702862D0 (en) | Therapeutic compounds | |
SI2219611T1 (sl) | Farmacevtske oblike za sproĺ äśanje aktivnih spojin | |
GB0717450D0 (en) | Medicament | |
GB0721333D0 (en) | Medicaments | |
GB0708188D0 (en) | Therapeutic compounds | |
GB0717571D0 (en) | Therapeutic compounds | |
GB0717572D0 (en) | Therapeutic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |